Search results

"Eine Unternehmensleitung ist auf die gesellschaftliche Akzeptanz seiner Anspruchsgruppen angewisen, da ansonsten diese der Unternehmung Ressourcen entziehen. Ökologieorientieres Unternehmensverhalten ist nicht nur eine freiwillige Herausforderung sondern wird immer mehr zu einer zentralen Voraussetzung einzelwirtschaftlichen Erfolgs. Die erfolgreiche Umsetzung qualitativen Wachstums auf Unternehmensebene bedingt ein erweiteres Rationalitätsverständnis. Damit einhergehend ändern sich auch die Erfolgsfaktoren des Managementverhaltens. Hieraus lassen sich Schlüsse und Ansatzpunkte für das betriebswirtschaftliche Informations- und Entscheidungsinstrumentarium aufzeigen." (Autorenreferat)

The owl's early flight : globalization and nationalism, an introduction / Eric Zuelow, Mitchell Young, and Andreas Sturm -- Nations in decline? : the erosion and persistence of modern national identities / Anthony D. Smith -- Comparing visions of the nation : the role of ethnicity, religion and diaspora nationalism in Armenian, Jewish, and Sikh relations to the homeland / William Safran -- When is the nation no longer? / Edward A. Tiryakian -- The appeal of nationhood : national celebrations & commemorations / Gabriella Elgenius -- The persistence of the Turkish nation in the Mausoleum of Mustafa Kemal Atatrk / Christopher S. Wilson -- Which "nation" persists? : the competing notions of the Thai nation as reflected in public monuments / Andreas Sturm -- The cross, the Madonna, and the Jew : persistent symbolic representations of the nation in Poland / Genevieve Zubrzycki -- -- National identity and tourism in 20th century Ireland : the role of collective re-imagining / Eric Zuelow -- The persistence of the Baltic nations under Soviet rule : an ethno-symbolist critique of modernist perspectives on the breakup of the USSR / Mark A. Jubulis I -- Croatian language policy : establishing national identity in the era of globalization / Mitchell Young -- National identity in the Hashemite Kingdom of Jordan : state made, still durable / Stefanie Nanes.

This unique collection examines why nations remain a vibrant and strong social cohesive despite the threat of globalization.

This new diagnostic consensus guideline is a joint project of the European Crohn's and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] that now merges the former ECCO-ESGAR Imaging Guideline and the former ECCO Endoscopy Guideline, also including laboratory parameters. It has been drafted by 30 ECCO and ESGAR members from 17 European countries. All the authors recognize th e work of and are grateful to previous ECCO and ESGAR members who contributed tocreating the earlier consensus guidelines on imaging and endoscopy. The former guidelines have been condensed into this new diagnostic consensus guideline which consists of two papers: the first detailing assessment at initial diagnosis, to monitor treat ment and for the detection of complications; the second dealing with the available scoring systems and general considerations regarding the different diagnostic tools. The strategy to define consensus was similar to that previously described in other ECCO consensus guidelines [available at www.ecco-ibd.eu]. Briefly, an open call for participants was made, with ECCO participants selected by the Guidelines' Committee of ECCO [known as GuiCom] on the basis of their publication record and a personal statement and ESGAR participants nominated by ESGAR. The following working parties were established: diagnostics at initial diagnosis, diagnostics for monitoring treatment in patients with known IBD, diagnostics for the detect ion of complications, scores for IBD, and general principles and technical aspects. Provisional guideline statements and supporting text were written following a comprehensive literature review, then refined following two voting rounds. The first voting round introduced a more comprehensive voting procedure, in which each Guidelines participants voted on all statements by explicitly reviewing those statements together with their respective supporting text and references. The second voting round included optional national representative participation of ECCO's 36 member countries and ESGAR's 28 member countries. The level of evidence was graded according to the Oxford Centre for Evidence-Based Medicine [www.cebm.net]. The ECCO statements were finalized by the authors at a face-to-face meeting in Barcelona in October 2017 and represent consensus with agreement of at least 80% of the present participants. Consensus statements are intended to be read in context with their qualifying comments and not in isolation. The supporting text was then finalised under the direction of each working group leader [SV, TK, GF, VA, EC], before being integrated by the consensus leaders [CM, JS, AS].

This new diagnostic consensus guideline is a joint project of the European Crohn's and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] that now merges the former ECCO-ESGAR Imaging Guideline and the former ECCO Endoscopy Guideline, also including laboratory parameters. It has been drafted by 30 ECCO and ESGAR members from 17 European countries. All the authors recognize the work of and are grateful to previous ECCO and ESGAR members who contributed to creating the earlier consensus guidelines on imaging and endoscopy. The former guidelines have been condensed into this new diagnostic consensus guideline which consists of two papers: the first detailing assessment at initial diagnosis, to monitor treat ment and for the detection of complications; the second dealing with the available scoring systems and general considerations regarding the different diagnostic tools. The strategy to define consensus was similar to that previously described in other ECCO consensus guidelines [available at www.ecco-ibd.eu]. Briefly, an open call for participants was made, with ECCO participants selected by the Guidelines' Committee of ECCO [known as GuiCom] on the basis of their publication record and a personal statement and ESGAR participants nominated by ESGAR. The following working parties were established: diagnostics at initial diagnosis, diagnostics for monitoring treatment in patients with known IBD, diagnostics for the detection of complications, scores for IBD, and general principles and technical aspects. Provisional guideline statements and supporting text were written following a comprehensive literature review, then refined following two voting rounds. The first voting round introduced a more comprehensive voting procedure, in which each Guidelines participants voted on all statements by explicitly reviewing those statements together with their respective supporting text and references. The second voting round included optional national representative participation of ECCO's 36 member countries and ESGAR's 28 member countries. The level of evidence was graded according to the Oxford Centre for Evidence-Based Medicine [www.cebm.net]. The ECCO statements were finalized by the authors at a face-to-face meeting in Barcelona in October 2017 and represent consensus with agreement of at least 80% of the present participants. Consensus statements are intended to be read in context with their qualifying comments and not in isolation. The supporting text was then finalised under the direction of each working group leader [SV, TK, GF, VA, EC], before being integrated by the consensus leaders [CM, JS, AS].